JHS Svendgaard Laboratories Limited (JHS.NS)
INR 14.49
(-2.03%)
INR 14.49
(-2.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.18 Million INR | -94.25% |
| 2022 | 20.69 Million INR | -59.09% |
| 2021 | 50.57 Million INR | -8.11% |
| 2020 | 55.04 Million INR | -17.22% |
| 2019 | 66.49 Million INR | 720.38% |
| 2018 | 8.1 Million INR | -26.55% |
| 2017 | 11.03 Million INR | 70.68% |
| 2016 | 6.46 Million INR | -42.74% |
| 2015 | 11.29 Million INR | 962.31% |
| 2014 | 1.06 Million INR | -99.2% |
| 2013 | 132.18 Million INR | -31.52% |
| 2012 | 193.01 Million INR | -27.68% |
| 2011 | 266.88 Million INR | -43.84% |
| 2010 | 475.23 Million INR | 14.75% |
| 2009 | 414.16 Million INR | -15.32% |
| 2008 | 489.07 Million INR | 47.01% |
| 2007 | 332.69 Million INR | 202.48% |
| 2006 | 109.98 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.18 Million INR | 0.0% |
| 2023 Q2 | 17.49 Million INR | 0.0% |
| 2023 FY | 1.18 Million INR | -94.25% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 20.69 Million INR | -59.09% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 50.14 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 20.69 Million INR | 0.0% |
| 2021 Q2 | 48.77 Million INR | 0.0% |
| 2021 Q4 | 50.57 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 50.57 Million INR | -8.11% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 61.66 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 55.04 Million INR | 0.0% |
| 2020 FY | 55.04 Million INR | -17.22% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 24.85 Million INR | 0.0% |
| 2019 FY | 66.49 Million INR | 720.38% |
| 2019 Q4 | 66.49 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 9.41 Million INR | 0.0% |
| 2018 FY | 8.1 Million INR | -26.55% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 8.1 Million INR | 0.0% |
| 2017 FY | 11.03 Million INR | 70.68% |
| 2017 Q2 | 9.52 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 11.03 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 6.46 Million INR | 0.0% |
| 2016 FY | 6.46 Million INR | -42.74% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 13.44 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q2 | 539 Thousand INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 11.29 Million INR | 0.0% |
| 2015 FY | 11.29 Million INR | 962.31% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 127.31 Million INR | 0.0% |
| 2014 FY | 1.06 Million INR | -99.2% |
| 2014 Q4 | 1.06 Million INR | 0.0% |
| 2013 Q2 | 162.33 Million INR | 0.0% |
| 2013 Q4 | 132.18 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 132.18 Million INR | -31.52% |
| 2012 Q2 | 631.92 Million INR | 0.0% |
| 2012 FY | 193.01 Million INR | -27.68% |
| 2012 Q4 | 193.01 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2011 FY | 266.88 Million INR | -43.84% |
| 2010 FY | 475.23 Million INR | 14.75% |
| 2009 FY | 414.16 Million INR | -15.32% |
| 2008 FY | 489.07 Million INR | 47.01% |
| 2007 FY | 332.69 Million INR | 202.48% |
| 2006 FY | 109.98 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ambica Agarbathies Aroma & Industries Limited | 673.21 Million INR | 99.823% |
| Bajaj Consumer Care Limited | 39.88 Million INR | 97.019% |
| BCL Industries Limited | 2.49 Billion INR | 99.952% |
| Colgate-Palmolive (India) Limited | 595.5 Million INR | 99.8% |
| Cupid Limited | - INR | -Infinity% |
| Dabur India Limited | 5.35 Billion INR | 99.978% |
| Emami Limited | 154.3 Million INR | 99.229% |
| Gillette India Limited | 500 Thousand INR | -137.8% |
| Godrej Consumer Products Limited | 358.3 Million INR | 99.668% |
| Hindustan Unilever Limited | 11.06 Billion INR | 99.989% |
| Honasa Consumer Limited | 1.12 Billion INR | 99.894% |
| Jyothy Labs Limited | 259.1 Million INR | 99.541% |
| Kaya Limited | 1.41 Billion INR | 99.916% |
| Marico Limited | 1.04 Billion INR | 99.886% |
| N.K Industries Limited | - INR | -Infinity% |
| Procter & Gamble Hygiene and Health Care Limited | - INR | -Infinity% |
| S H Kelkar and Company Limited | 1.73 Billion INR | 99.931% |